Elevated circulating concentrations of FGF23 have been implicated as a potential contributor to the development of congestive heart failure, left ventricular hypertrophy, atrial fibrillation, and hypertension, regardless of the presence or absence of impaired kidney function5–8. Here, FGF23 is linked to Hypertension.